The U.S. personalized medicine market is poised for significant expansion, fueled by advances in genomics , biotechnology , and tailored treatments. The market is expected to grow from USD 152.34 billion in 2025 to USD 331.95 billion by 2035, at a CAGR of 8.10%.

U.S. Personalized Medicine Market Statical Scope

The market is majorly driven by advancements in genomics, targeted therapies, and high demand for oncology applications.

The U.S. personalized medicine market is also propelled due to major healthcare infrastructure, artificial intelligence integration, and rising demand for preventive care and customized treatments. Advanced technology in the form of NGS and AI, helpful to enhance the availability of biomarkers and lower diagnostic costs, also helps to fuel the growth of the market. Higher demand for personalized nutrition and wellness to improve the lifestyle of a patient and lower the chances of chronic diseases is also a major market driver.

U.S. Personalized Medicine Market Share, By Product, 2025 (%)

• Personalized Medicine Diagnostics- The segment accounts for 28.40% of the market share with the help of diagnostic tools and tests tailored as per an individual's genetic profile for precise disease detection.
• Personalized Medicine Therapeutics- The segment accounts for 31.20% of market share due to higher demand for targeted treatments as per an individual's genetic and molecular profile.
• Personalized Medical Care- The segment holds 14.10% of market share due to customized healthcare services, inclusive of patient-specific data for treatment planning.
• Personalized Nutrition and Wellness- The segment holds 26.30% of the market share as it signifies the importance of tailored nutrition and wellness based on a patient's genetic and lifestyle data.

U.S. Personalized Medicine Market Share, By End Use, 2025 (%)

• Hospitals- The segment has a significant share of 46.80% in 2025 as it is a primary healthcare institution providing personalized treatments and diagnostics.
• Diagnostic Centers- The segment has a notable share of 24.60% market as it focuses on specialized facilities of genetic and molecular testing services. Early disease detection, cost-efficiency, and high-throughput screening solutions also help to propel the growth of the market.
• Research and Academic Institutes- The segment holds 18.20% of the market share as it focuses on organizations engaged in research and development of personalized medicine technology.
• Others- The segment has 10.40% of the market share as it is inclusive of clinics and specialty care providers, along with personalized medicine services.

Top Companies in the U.S. Personalized Medicine Market

• GE Healthcare
• Illumina, Inc.
• ASURAGEN, INC.
• Abbott
• Dako A/S
• Exact Sciences Corporation
• Danaher Corporation (Cepheid, Inc.)
• Decode Genetics, Inc.
• QIAGEN
• Exagen Inc.
• Precision Biologics
• Celera Diagnostics LLC.
• Biogen
• Genelex
• International Business Machines Corporation (IBM)
• Genentech, Inc.

Segments Covered in the Report

By Product

• Personalized Medicine Diagnostics
• Personalized Medicine Therapeutics
• Personalized Medical Care
• Personalized Nutrition & Wellness

By End Use

• Hospitals
• Diagnostic Centers
• Research & Academic Institutes
• Others